rediff.com
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23
Sales 926.07 1,085.29 945.18 1,014.58 848.86
Operating profit 227.15 327.18 273.65 276.90 144.53
Interest 1.42 2.36 2.27 0.75 1.21
Gross profit 259.41 338.55 323.54 307.61 180.07
EPS (Rs) 12.88 17.42 16.81 16.78 9.28
Quarterly  results in details
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23
Other income 33.68 13.73 52.16 31.46 36.75
Stock adjustment -59.42 31.01 -28.16 34.40 -6.03
Raw material 259.03 239.04 223.55 217.81 231.89
Power and fuel - - - - -
Employee expenses 215.97 216.41 205.48 196.30 207.06
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 283.34 271.65 270.66 289.17 271.41
Provisions made - - - - -
Depreciation 33.47 33.41 33.04 32.24 32.11
Taxation 63.25 84.99 78.14 63.33 30.75
Net profit / loss 162.69 220.15 212.36 212.04 117.21
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 25.27 25.27 25.27 25.27 25.27
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 24.53 30.15 28.95 27.29 17.03
GPM (%) 27.03 30.80 32.44 29.41 20.33
NPM (%) 16.95 20.03 21.29 20.27 13.23
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close